STOCK TITAN

Neutra's Aggressive 2022 Strategy Roars Out of the Gates in Quick-Paced January

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

Neutra Corp. (OTC PINK:NTRR) has launched a dynamic sales and marketing initiative at the start of 2022, including a new product line by its subsidiary VIVIS, featuring CBDa and CBGa gummies. These compounds have shown potential in preventing COVID-19's penetration into human cells, according to recent studies. The company aims for continued revenue growth, emphasizing there are no plans for a reverse stock split despite rumors. Enhanced advertising efforts and redesigned e-commerce sites for VIVIS and Deity Wellness aim to attract consumer interest and boost sales further.

Positive
  • Launch of new CBDa and CBGa gummies, potentially effective against COVID-19.
  • Continued revenue growth reported over the last few quarters.
  • Strong sales and marketing initiatives to enhance consumer interest.
  • No plans for a reverse stock split, indicating stability.
Negative
  • None.

KATY, TX / ACCESSWIRE / January 31, 2022 / Neutra Corp. (OTC PINK:NTRR) reports that it has kicked off 2022 in strong fashion launching several dynamic sales and marketing initiatives as well as launching a new product for subsidiary VIVIS. The company expects these efforts will help extend the positive success it enjoyed last year.

"We couldn't ask for a better start to a new year," said Neutra CEO. "The pace we're setting in these first few weeks of 2022 bodes well for another exponential growth year. We've set some high goals, but one thing that's definitely not in our plans is a reverse split. I know there are rumors out there; let me dispel those now. There are no plans for a reverse split at this time or in the near future. We have come a long way since 2018 and we have seen significant growth in revenue in the last few quarters. We hope to continue that trend. So there's simply no reason to change structure in light of our current positive situation."

Neutra subsidiary VIVIS opened 2022 with the announcement of a new line of gummies. The gummies contain cannabidiolic acid (CBDa) and cannabigerolic acid (CBGa), compounds recent university research has indicated could be effective in preventing the coronavirus that causes COVID-19 from penetrating human cells. Bloomberg recently reported on the study and its results.

Neutra has been as equally forceful on the sales and marketing side. The company has started a strong new sales push to boost revenues. The sales push will be aided by advertising and marketing campaigns designed to draw consumer interest and get people to visit Neutra's e-commerce websites. VIVIS' and Deity Wellness' websites have received a fresh, new look to coincide with the advertising and marketing efforts.

About Neutra Corp.
Neutra Corp. (OTC PINK:NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food, and drug, and environmental purification sectors are creating a new kind of world culture-one where in which consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate. For more information, visit the Company's website at http://www.NeutraInc.com.

NOTICE REGARDING FORWARD-LOOKING STATEMENTS
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words 'believes,' 'expects,' 'anticipate' or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.

Neutra Contact:
Sydney Jim
888-433-4033
info@neutrainc.com

SOURCE: Neutra Corp



View source version on accesswire.com:
https://www.accesswire.com/686455/Neutras-Aggressive-2022-Strategy-Roars-Out-of-the-Gates-in-Quick-Paced-January

FAQ

What new product did Neutra Corp. launch in 2022?

Neutra Corp. launched a line of gummies containing CBDa and CBGa, which may help prevent COVID-19 from penetrating human cells.

What is the stock symbol for Neutra Corp.?

The stock symbol for Neutra Corp. is NTRR.

Are there any plans for a reverse stock split by Neutra Corp.?

No, Neutra Corp. has stated there are no plans for a reverse stock split at this time or in the near future.

How is Neutra Corp. planning to boost sales in 2022?

Neutra Corp. is implementing strong sales and marketing initiatives, including new advertising campaigns and redesigned e-commerce websites.

What indicators show Neutra Corp.'s revenue growth?

Neutra Corp. reported significant revenue growth in the last few quarters, indicating a positive financial trend.

NEUTRA CORPORATION

OTC:NTRR

NTRR Rankings

NTRR Latest News

NTRR Stock Data

875.37k
2.90B
0.69%
Biotechnology
Healthcare
Link
United States of America
Sugar Land